SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000899140-00-000274
Filing Date
2000-06-16
Accepted
2000-06-16 00:00:00
Documents
5
Group Members
E.M. WARBURG, PINCUS & CO., LLCWARBURG PINCUS EQUITY PARTNERS LPWARBURG, PINCUS & CO.WARBURG, PINCUS EQUITY PARTNERS, L.P.

Document Format Files

Seq Description Document Type Size
1 INITIAL FILING ON SCHEDULE 13D 0001.txt SC 13D 30064
2 JOINT FILING AGREEMENT 0002.txt EX-99.1 18201
3 STOCK PURCHASE AGREEMENT 0003.txt EX-99.2 52080
4 CERTIFICATE OF DESIGNATIONS 0004.txt EX-99.3 29273
5 REGISTRATION RIGHTS AGREEMENT 0005.txt EX-99.4 45255
  Complete submission text file 0000899140-00-000274.txt   177440
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Subject) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-47221 | Film No.: 656407
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address 466 LEXINGTON AVE. NEW YORK NY 10017 2128780600
WARBURG PINCUS EQUITY PARTNERS LP (Filed by) CIK: 0001075598 (see all company filings)